IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment)

Inclusion Criteria: * Ambulatory women, * Caucasian, Oriental or Multiracial * not previously diagnosed for osteoporosis. Exclusion Criteria: * Females of black descent and for the US african american are excluded because of the very low incidence of postmenopausal osteoporosis * and having used oral or parenteral glucocorticoids (\>= 5 mg prednisone or equivalent per day) within 3 months of starting study drug or for more than one month within six months prior to study entry. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.